Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110294708B details a metal-free synthesis of trifluoroethylselenophenanthridine derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel green electrochemical route for 6-7-5 fused ring sulfonamides. Metal-free, mild conditions, scalable for high-purity pharmaceutical intermediates manufacturing.
Patent CN110028448B details a cost-effective copper-catalyzed synthesis of 3-hydroxy-2,3-dihydroisoquinoline-1,4-dione intermediates, offering significant supply chain advantages.
Novel patent CN115403505B enables efficient thioester synthesis using sulfonyl chloride. Delivers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel Pd-catalyzed one-pot method for high-purity intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN115215810B reveals catalyst-free synthesis for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability for global buyers.
Novel patent CN104045592A details mild synthesis of 5-fluoroindole-2-one. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed route for chroman amides using nitroarenes. Reduces cost and complexity in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN107641068A reveals a palladium-catalyzed route for indanone derivatives offering significant supply chain stability and reduced environmental waste for manufacturers.
Patent CN107501267B reveals Pd-catalyzed asymmetric allylic amination for high-purity nucleoside intermediates. Enables cost reduction and supply chain reliability.
Novel nickel-catalyzed route for tetralone skeletons offering high ee values and cost-effective manufacturing for pharmaceutical intermediates.
Novel cyclization route for spiro-piperidine intermediates offering high yield and scalability for pharmaceutical manufacturing.
Patent CN115353511A details a safe, multicomponent synthesis of carbonyl-bridged biheterocycles using in-situ CO generation, offering cost-effective pharmaceutical intermediate manufacturing.
Novel iron-catalyzed C-H/N-H activation route for pyrrolo[1,2-a]indole derivatives. Offers mild conditions, high yields, and cost-effective scalability for API manufacturing.
Patent CN115353511A details a safe, multi-component Pd-catalyzed carbonylation route for indolinone-imidazole derivatives, offering significant supply chain advantages.
Novel elemental sulfur-promoted synthesis avoids peroxides and heavy metals. Cost-effective, scalable route for high-purity pharmaceutical intermediates ensuring supply chain reliability.
Novel nickel-catalyzed method reduces costs and improves safety for 2-pyrrolidone derivatives manufacturing ensuring reliable supply chain continuity.
Patent CN110467555B reveals a novel chiral phosphoric acid catalyzed method for synthesizing axially chiral indoles with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN111705329B details a green electrochemical route for 5-arylthiouracil. Eliminates oxidants, uses electrons, offers high yield and easy purification for pharma intermediates.
Patent CN115260080B reveals a one-step palladium-catalyzed carbonylation route. This method offers significant supply chain stability and cost optimization for pharmaceutical intermediates.